Meridian Bioscience Reports Record Setting First Quarter Fiscal 2021 Operating Results and Raises Full Year Fiscal 2021 Guidance
05 févr. 2021 07h30 HE
|
Meridian Bioscience Inc.
CINCINNATI, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the first quarter ended December 31, 2020. First Quarter 2021...
Meridian Bioscience Expands Production Capacity with Support from NIH, JobsOhio, and the Village of Newtown
03 févr. 2021 10h30 HE
|
Meridian Bioscience Inc.
CINCINNATI, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it will...
Meridian’s Air-Dryable Master Mixes Replace Lyophilization in the Manufacturing of Molecular Assays
02 févr. 2021 08h00 HE
|
Meridian Bioscience Inc.
CINCINNATI, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that...
Meridian Bioscience to Hold First Quarter Fiscal 2021 Financial Results Conference Call on February 5, 2021
13 janv. 2021 16h30 HE
|
Meridian Bioscience Inc.
CINCINNATI, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report first quarter fiscal...
Meridian Bioscience Announces Better-than-expected Preliminary First Quarter Fiscal 2021 Revenue Results
07 janv. 2021 08h00 HE
|
Meridian Bioscience Inc.
CINCINNATI, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) a provider of diagnostic testing solutions and life science raw materials, announced preliminary financial...
Meridian Bioscience to Participate in H. C. Wainright Bioconnect 2021 Virtual Conference
06 janv. 2021 09h30 HE
|
Meridian Bioscience Inc.
CINCINNATI, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) a provider of diagnostic testing solutions and life science raw materials, announced today its participation in...
Meridian Bioscience receives NIH Award for supporting rapid development of Revogene® molecular test for SARS-CoV-2
16 déc. 2020 15h00 HE
|
Meridian Bioscience Inc.
CINCINNATI, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it has been...
Meridian Bioscience submits application to FDA for Emergency Use Authorization for SARS-CoV-2 molecular assay
08 déc. 2020 10h17 HE
|
Meridian Bioscience Inc.
CINCINNATI, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it has...
Meridian Launches its Novel Air-Dryable RT-qPCR Mix, Further Decreases Costs and Simplifies Workflows for COVID-19 Molecular Test Manufacturers
03 déc. 2020 10h00 HE
|
Meridian Bioscience Inc.
CINCINNATI, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that...
Meridian Bioscience Participates in Piper Sandler 32nd Annual Virtual Healthcare Conference
23 nov. 2020 10h00 HE
|
Meridian Bioscience Inc.
CINCINNATI, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today its participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference. Jack Kenny,...